Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-methyl-D-aspartate receptor subunit GluN2A is a protein encoded by the GRIN2A gene and serves as a regulatory subunit in NMDA receptors, a subclass of glutamate-gated ion channels highly permeable to calcium ions. NMDA receptors are heterotetramers typically formed by two GluN1 and two GluN2A–D subunits, with GluN2A contributing unique channel gating properties, high calcium permeability, and synaptic localization, especially in adult neurons. GluN2A-containing NMDA receptors are crucial for learning, memory, and synaptic plasticity, and disproportionately expressed at synaptic sites due to their interactions with scaffold proteins like PSD-95. Pathological changes in GluN2A function or localization are involved in neurodegenerative and neurodevelopmental diseases. Selective targeting of NMDA receptors containing GluN2A subunits represents a promising therapeutic strategy for neuroprotection and cognitive modulation, but with considerable safety concerns due to the importance of this receptor in normal brain function[1][2][3][8].
Noncompetitive inhibition (memantine, ketamine block channel pore); Competitive antagonism at the glutamate site (not commonly used clinically, but utilized in experiments); Allosteric modulation (zinc restricts activity; experimental selective antagonists act via allosteric sites)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate receptor subunit GluN2A (GluN2A).